Market cap: $
Exchange: NAS
Sector: Health Technology
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include AMPYRA (dalfampridine), INBRIJA (levodopa inhalation powder), BTT1023 (timolumab), SYN120, rHIgM22, and GGF2 (Cimaglermin alfa). The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
Company Name
Acorda Therapeutics Inc
Average Volume (10 days)
0
Average Volume (30 days)
0
Moving Average (50 days)
$0
Moving Average (200 days)
$0
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
0
Shares Outstanding
1,242,098
52-Week High Split Adjust Only
0
52-Week Low Split Adjust Only
0
Employee Count
344
Beta
0
Next Earnings Date
TTM Dividend Rate Per Share
0
Past 5 days
0%
Past 30 days
0%
Past 3 months
0%
Past 6 months
0%
Past year
0%
Past 2 years
0%
Past 5 years
0%
Max % Change
0%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Acorda Therapeutics Inc | ACOR | 0.23 | 0.17 | -0.5 | 0.23 | 1.01 |
| Peer Avg | N/A | 7.70 | 2.46 | -15.1 | 7.70 | 7.29 |
| Biomarin Pharmaceutical Inc. - Registered Shares | BMRN | 7.66 | 3.39 | -151.2 | 7.66 | 7.65 |
| Repligen Corp. | RGEN | 23.15 | 6.44 | 80.9 | 23.15 | 21.51 |
| Coherus Biosciences Inc | CHRS | n/a | n/a | 29.2 | n/a | n/a |
| Affimed N.V. | AFMD | n/a | n/a | -19.3 | n/a | n/a |